Huadong Medicine (000963) Income Statement & Earnings

38.68
-0.21-0.54%

Market Closed Jan 16 15:00 CST

67.85BMarket Cap18.35P/E (TTM)

Huadong Medicine (000963) Income Statement

All

YOY

Hide blank lines

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

Total operating revenue

3.77%32.66B

3.39%21.67B

3.12%10.74B

3.16%41.91B

3.56%31.48B

2.84%20.97B

2.93%10.41B

7.71%40.62B

9.10%30.39B

12.02%20.39B

Operating revenue

3.77%32.66B

3.39%21.67B

3.12%10.74B

3.16%41.91B

3.56%31.48B

2.84%20.97B

2.93%10.41B

7.71%40.62B

9.10%30.39B

12.02%20.39B

Other operating revenue

----

16.18%166.11M

----

9.62%397.3M

----

4.01%142.98M

----

60.37%362.43M

----

50.97%137.47M

Total operating cost

3.54%29.29B

2.87%19.42B

3.09%9.62B

1.11%37.49B

2.72%28.29B

2.35%18.88B

2.42%9.33B

7.27%37.08B

8.33%27.54B

11.67%18.44B

Operating cost

2.28%21.72B

1.54%14.33B

1.84%7.21B

1.92%27.99B

2.51%21.23B

1.38%14.11B

4.21%7.08B

6.93%27.46B

8.97%20.71B

13.67%13.92B

Operating tax surcharges

5.61%172.98M

3.22%114.59M

1.65%57.27M

7.76%250.64M

5.63%163.79M

4.05%111.01M

5.99%56.33M

11.65%232.59M

6.38%155.06M

11.03%106.69M

Operating expense

1.36%4.79B

-1.40%3.23B

-6.58%1.47B

-3.56%6.41B

1.40%4.73B

6.19%3.27B

-4.16%1.57B

4.90%6.65B

3.53%4.66B

1.68%3.08B

Administration expense

-7.55%1.09B

1.49%725.3M

6.03%355.4M

-1.61%1.4B

6.62%1.18B

-0.95%714.63M

1.54%335.17M

13.73%1.42B

15.33%1.11B

26.12%721.48M

Financial expense

-70.20%11.33M

-4.27%22.42M

93.49%14.62M

-56.51%22.26M

-40.63%38.02M

-58.06%23.42M

-74.08%7.56M

-34.59%51.19M

230.55%64.03M

925.12%55.85M

-Interest expense (Financial expense)

-0.05%86.55M

1.07%56.15M

12.47%25.92M

-15.32%101.2M

2.69%86.59M

0.27%55.55M

-33.12%23.05M

-6.38%119.51M

51.30%84.32M

32.55%55.4M

-Interest Income (Financial expense)

9.60%-72.33M

14.17%-45.61M

-13.94%-27.81M

-10.58%-104M

-29.72%-80.01M

-60.93%-53.14M

-95.41%-24.41M

9.00%-94.05M

18.60%-61.68M

33.90%-33.02M

Research and development

58.92%1.51B

55.44%999.67M

82.99%515.38M

12.19%1.43B

12.83%948.66M

15.17%643.11M

6.08%281.64M

25.08%1.27B

6.68%840.79M

-1.45%558.41M

Credit Impairment Loss

-44.91%-83.96M

----

-335.42%-112.18M

-37.88%-57.94M

-59.03%-57.94M

----

62.49%-25.76M

41.61%-42.02M

49.38%-36.43M

Asset Impairment Loss

----

-528.94%-41.01M

----

-70.60%-6.52M

---3.18M

Other net revenue

-190.36%-23.95M

-83.68%-13.14M

323.99%16.48M

1.11%-87.95M

118.10%26.51M

95.01%-7.15M

85.10%-7.36M

-5.18%-88.94M

-196.03%-146.45M

-306.01%-143.26M

Fair value change income

----

---25.36K

-148.32%-13.76M

---6.62M

---5.1M

Invest income

-37.66%-119.37M

-40.59%-67.27M

9.62%-42.62M

41.20%-129.19M

48.64%-86.71M

65.05%-47.85M

23.63%-47.16M

-55.21%-219.71M

-70.25%-168.84M

-155.96%-136.89M

-Including: Investment income associates

-37.92%-75.25M

-40.03%-35.37M

24.68%-28.25M

63.66%-68.45M

62.45%-54.56M

79.03%-25.26M

28.99%-37.5M

-62.94%-188.39M

-79.47%-145.31M

-179.12%-120.43M

Asset deal income

-16.53%1.82M

-225.85%-6.2M

-1,055.84%-14.54M

-226.47%-5.46M

-39.32%2.18M

39.99%4.93M

169.15%1.52M

-47.69%4.32M

-35.68%3.59M

-58.62%3.52M

Other revenue

5.07%177.56M

53.98%144.29M

92.22%73.64M

15.88%199.89M

139.29%168.98M

169.17%93.71M

162.72%38.31M

85.91%172.49M

-39.17%70.62M

-57.36%34.81M

Operating profit

4.21%3.35B

7.80%2.24B

5.61%1.13B

25.25%4.32B

18.71%3.22B

15.72%2.08B

12.39%1.07B

12.79%3.45B

13.49%2.71B

9.25%1.8B

Add:Non operating Income

-24.23%5.64M

-20.38%4.16M

-40.64%769.1K

74.11%88.01M

110.42%7.44M

75.66%5.22M

-6.74%1.3M

564.38%50.55M

-29.74%3.54M

-31.53%2.97M

Less:Non operating expense

5.28%93.61M

43.89%54.37M

439.64%28.08M

196.70%111.23M

270.46%88.91M

131.83%37.78M

-13.99%5.2M

-1.18%37.49M

-11.34%24M

88.17%16.3M

Total profit

4.11%3.26B

7.06%2.19B

3.44%1.1B

24.11%4.3B

16.58%3.13B

14.76%2.05B

12.53%1.07B

14.35%3.47B

13.68%2.69B

8.73%1.79B

Less:Income tax cost

-8.84%520.76M

8.19%389.83M

-8.16%190.97M

30.30%807.33M

15.51%571.28M

4.36%360.34M

9.82%207.94M

24.29%619.59M

38.06%494.56M

19.91%345.28M

Net profit

6.99%2.74B

6.82%1.8B

6.25%913.98M

22.76%3.49B

16.82%2.56B

17.25%1.69B

13.20%860.25M

12.39%2.85B

9.33%2.19B

6.35%1.44B

Net profit from continuing operation

6.99%2.74B

6.82%1.8B

6.25%913.98M

22.76%3.49B

16.82%2.56B

17.25%1.69B

13.20%860.25M

12.39%2.85B

9.33%2.19B

6.35%1.44B

Less:Minority Profit

-2,282.43%-6.06M

-47.30%-11.5M

66.56%-724.3K

-337.77%-17.92M

-93.83%277.57K

-229.42%-7.81M

-146.68%-2.17M

-77.44%7.54M

-81.89%4.5M

-54.77%6.03M

Net profit of parent company owners

7.24%2.75B

7.01%1.81B

6.06%914.71M

23.72%3.51B

17.05%2.56B

18.29%1.7B

14.18%862.41M

13.59%2.84B

10.48%2.19B

6.96%1.43B

Earning per share

Basic earning per share

7.09%1.5682

6.39%1.0293

5.98%0.5224

23.60%2.0046

17.06%1.4644

18.07%0.9675

14.20%0.4929

13.55%1.6219

10.47%1.251

6.96%0.8194

Diluted earning per share

7.02%1.5666

6.81%1.0346

5.78%0.5213

23.61%2.0034

17.08%1.4639

18.27%0.9686

14.21%0.4928

13.47%1.6207

10.41%1.2503

6.91%0.819

Other composite income

371.61%83.36M

477.95%23.76M

102.13%82.04M

-120.31%-10.26M

554.51%17.68M

29.29%-6.29M

229.47%40.59M

223.84%50.51M

79.56%-3.89M

90.95%-8.89M

Other composite income of parent company owners

371.61%83.36M

477.95%23.76M

102.13%82.04M

-120.31%-10.26M

554.51%17.68M

29.29%-6.29M

229.47%40.59M

223.84%50.51M

79.56%-3.89M

90.95%-8.89M

Total composite income

9.49%2.83B

8.63%1.83B

10.57%996.03M

20.26%3.48B

17.84%2.58B

17.54%1.68B

23.64%900.84M

16.26%2.9B

10.18%2.19B

13.96%1.43B

Total composite income of parent company owners

9.74%2.83B

8.81%1.84B

10.38%996.75M

21.20%3.5B

18.07%2.58B

18.58%1.69B

24.74%903M

17.53%2.89B

11.35%2.19B

14.70%1.42B

Total composite income of minority owners

-2,282.43%-6.06M

-47.30%-11.5M

66.56%-724.3K

-337.77%-17.92M

-93.83%277.57K

-229.42%-7.81M

-146.68%-2.17M

-77.44%7.54M

-81.89%4.5M

-54.77%6.03M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023
Total operating revenue	3.77%32.66B	3.39%21.67B	3.12%10.74B	3.16%41.91B	3.56%31.48B	2.84%20.97B	2.93%10.41B	7.71%40.62B	9.10%30.39B	12.02%20.39B
Operating revenue	3.77%32.66B	3.39%21.67B	3.12%10.74B	3.16%41.91B	3.56%31.48B	2.84%20.97B	2.93%10.41B	7.71%40.62B	9.10%30.39B	12.02%20.39B
Other operating revenue	----	16.18%166.11M	----	9.62%397.3M	----	4.01%142.98M	----	60.37%362.43M	----	50.97%137.47M
Total operating cost	3.54%29.29B	2.87%19.42B	3.09%9.62B	1.11%37.49B	2.72%28.29B	2.35%18.88B	2.42%9.33B	7.27%37.08B	8.33%27.54B	11.67%18.44B
Operating cost	2.28%21.72B	1.54%14.33B	1.84%7.21B	1.92%27.99B	2.51%21.23B	1.38%14.11B	4.21%7.08B	6.93%27.46B	8.97%20.71B	13.67%13.92B
Operating tax surcharges	5.61%172.98M	3.22%114.59M	1.65%57.27M	7.76%250.64M	5.63%163.79M	4.05%111.01M	5.99%56.33M	11.65%232.59M	6.38%155.06M	11.03%106.69M
Operating expense	1.36%4.79B	-1.40%3.23B	-6.58%1.47B	-3.56%6.41B	1.40%4.73B	6.19%3.27B	-4.16%1.57B	4.90%6.65B	3.53%4.66B	1.68%3.08B
Administration expense	-7.55%1.09B	1.49%725.3M	6.03%355.4M	-1.61%1.4B	6.62%1.18B	-0.95%714.63M	1.54%335.17M	13.73%1.42B	15.33%1.11B	26.12%721.48M
Financial expense	-70.20%11.33M	-4.27%22.42M	93.49%14.62M	-56.51%22.26M	-40.63%38.02M	-58.06%23.42M	-74.08%7.56M	-34.59%51.19M	230.55%64.03M	925.12%55.85M
-Interest expense (Financial expense)	-0.05%86.55M	1.07%56.15M	12.47%25.92M	-15.32%101.2M	2.69%86.59M	0.27%55.55M	-33.12%23.05M	-6.38%119.51M	51.30%84.32M	32.55%55.4M
-Interest Income (Financial expense)	9.60%-72.33M	14.17%-45.61M	-13.94%-27.81M	-10.58%-104M	-29.72%-80.01M	-60.93%-53.14M	-95.41%-24.41M	9.00%-94.05M	18.60%-61.68M	33.90%-33.02M
Research and development	58.92%1.51B	55.44%999.67M	82.99%515.38M	12.19%1.43B	12.83%948.66M	15.17%643.11M	6.08%281.64M	25.08%1.27B	6.68%840.79M	-1.45%558.41M
Credit Impairment Loss	-44.91%-83.96M	-44.91%-83.96M	----	-335.42%-112.18M	-37.88%-57.94M	-59.03%-57.94M	----	62.49%-25.76M	41.61%-42.02M	49.38%-36.43M
Asset Impairment Loss	----	----	----	-528.94%-41.01M	----	----	----	-70.60%-6.52M	---3.18M	---3.18M
Other net revenue	-190.36%-23.95M	-83.68%-13.14M	323.99%16.48M	1.11%-87.95M	118.10%26.51M	95.01%-7.15M	85.10%-7.36M	-5.18%-88.94M	-196.03%-146.45M	-306.01%-143.26M
Fair value change income	----	----	----	----	----	----	---25.36K	-148.32%-13.76M	---6.62M	---5.1M
Invest income	-37.66%-119.37M	-40.59%-67.27M	9.62%-42.62M	41.20%-129.19M	48.64%-86.71M	65.05%-47.85M	23.63%-47.16M	-55.21%-219.71M	-70.25%-168.84M	-155.96%-136.89M
-Including: Investment income associates	-37.92%-75.25M	-40.03%-35.37M	24.68%-28.25M	63.66%-68.45M	62.45%-54.56M	79.03%-25.26M	28.99%-37.5M	-62.94%-188.39M	-79.47%-145.31M	-179.12%-120.43M
Asset deal income	-16.53%1.82M	-225.85%-6.2M	-1,055.84%-14.54M	-226.47%-5.46M	-39.32%2.18M	39.99%4.93M	169.15%1.52M	-47.69%4.32M	-35.68%3.59M	-58.62%3.52M
Other revenue	5.07%177.56M	53.98%144.29M	92.22%73.64M	15.88%199.89M	139.29%168.98M	169.17%93.71M	162.72%38.31M	85.91%172.49M	-39.17%70.62M	-57.36%34.81M
Operating profit	4.21%3.35B	7.80%2.24B	5.61%1.13B	25.25%4.32B	18.71%3.22B	15.72%2.08B	12.39%1.07B	12.79%3.45B	13.49%2.71B	9.25%1.8B
Add:Non operating Income	-24.23%5.64M	-20.38%4.16M	-40.64%769.1K	74.11%88.01M	110.42%7.44M	75.66%5.22M	-6.74%1.3M	564.38%50.55M	-29.74%3.54M	-31.53%2.97M
Less:Non operating expense	5.28%93.61M	43.89%54.37M	439.64%28.08M	196.70%111.23M	270.46%88.91M	131.83%37.78M	-13.99%5.2M	-1.18%37.49M	-11.34%24M	88.17%16.3M
Total profit	4.11%3.26B	7.06%2.19B	3.44%1.1B	24.11%4.3B	16.58%3.13B	14.76%2.05B	12.53%1.07B	14.35%3.47B	13.68%2.69B	8.73%1.79B
Less:Income tax cost	-8.84%520.76M	8.19%389.83M	-8.16%190.97M	30.30%807.33M	15.51%571.28M	4.36%360.34M	9.82%207.94M	24.29%619.59M	38.06%494.56M	19.91%345.28M
Net profit	6.99%2.74B	6.82%1.8B	6.25%913.98M	22.76%3.49B	16.82%2.56B	17.25%1.69B	13.20%860.25M	12.39%2.85B	9.33%2.19B	6.35%1.44B
Net profit from continuing operation	6.99%2.74B	6.82%1.8B	6.25%913.98M	22.76%3.49B	16.82%2.56B	17.25%1.69B	13.20%860.25M	12.39%2.85B	9.33%2.19B	6.35%1.44B
Less:Minority Profit	-2,282.43%-6.06M	-47.30%-11.5M	66.56%-724.3K	-337.77%-17.92M	-93.83%277.57K	-229.42%-7.81M	-146.68%-2.17M	-77.44%7.54M	-81.89%4.5M	-54.77%6.03M
Net profit of parent company owners	7.24%2.75B	7.01%1.81B	6.06%914.71M	23.72%3.51B	17.05%2.56B	18.29%1.7B	14.18%862.41M	13.59%2.84B	10.48%2.19B	6.96%1.43B
Earning per share
Basic earning per share	7.09%1.5682	6.39%1.0293	5.98%0.5224	23.60%2.0046	17.06%1.4644	18.07%0.9675	14.20%0.4929	13.55%1.6219	10.47%1.251	6.96%0.8194
Diluted earning per share	7.02%1.5666	6.81%1.0346	5.78%0.5213	23.61%2.0034	17.08%1.4639	18.27%0.9686	14.21%0.4928	13.47%1.6207	10.41%1.2503	6.91%0.819
Other composite income	371.61%83.36M	477.95%23.76M	102.13%82.04M	-120.31%-10.26M	554.51%17.68M	29.29%-6.29M	229.47%40.59M	223.84%50.51M	79.56%-3.89M	90.95%-8.89M
Other composite income of parent company owners	371.61%83.36M	477.95%23.76M	102.13%82.04M	-120.31%-10.26M	554.51%17.68M	29.29%-6.29M	229.47%40.59M	223.84%50.51M	79.56%-3.89M	90.95%-8.89M
Total composite income	9.49%2.83B	8.63%1.83B	10.57%996.03M	20.26%3.48B	17.84%2.58B	17.54%1.68B	23.64%900.84M	16.26%2.9B	10.18%2.19B	13.96%1.43B
Total composite income of parent company owners	9.74%2.83B	8.81%1.84B	10.38%996.75M	21.20%3.5B	18.07%2.58B	18.58%1.69B	24.74%903M	17.53%2.89B	11.35%2.19B	14.70%1.42B
Total composite income of minority owners	-2,282.43%-6.06M	-47.30%-11.5M	66.56%-724.3K	-337.77%-17.92M	-93.83%277.57K	-229.42%-7.81M	-146.68%-2.17M	-77.44%7.54M	-81.89%4.5M	-54.77%6.03M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"